Corix Bioscience

Corix Bioscience Net Margin

The Net Profit Margin of Corix Bioscience (CXBS) as of Oct 5, 2026 is -638.63 %. In the previous year, Net Profit Margin was -573.44 % — a change of 11.37% (lower).

Net Margin

-638.63 %

YoY

11.37%

Last updated:

Net Profit Margin of Corix Bioscience is 2026 -638.63 % . Net Profit Margin of Corix Bioscience was 2025 -573.44 % . It decreases by 11.37% lower compared to the previous year.

For Corix Bioscience, the net margin of -638.6% is down versus -573.4% a few years ago.

The Corix Bioscience Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2015
-573.44 USD
Jan 1, 2016
-638.63 USD
The Corix Bioscience Net Margin history
YEARNet MarginYoY
-638.63 %+11.37%
-573.44 %—
Access this data via the Eulerpool API
Get Free API Key

Corix Bioscience Stock analysis

What does Corix Bioscience do? Corix Bioscience is a company specialized in the production of cannabinoid-based products. It was founded in 2014 under the name American Housing Income Trust, a holding company focused on the American real estate market. In 2017, the company decided to restructure and change its name to Corix Bioscience. Since then, the company has become one of the leading manufacturers of CBD oils and other cannabinoid-based products. Corix Bioscience's business model is based on state-of-the-art technologies and innovation in the cannabinoid industry. The company collaborates with other firms to develop new products tailored to patient needs. The company aims to provide patients with a natural and safe alternative to conventional medical therapy. Corix Bioscience has five divisions. These include "Corix Bioscience," which focuses on the development of CBD-based products for the European market. "Corix Health" develops cannabinoid-based products specifically tailored to patient needs. "Subsidiaries" is responsible for collaborating with other companies to expand the product offering. "Licensing" offers licenses for technologies and rights to use innovative products. "Research and Development" focuses on advancing research and technologies in the cannabinoid industry. One of Corix Bioscience's most well-known products is CBD oil. It is extracted from specially bred hemp plants and is used for pain relief, anxiety, and other ailments. The company also offers CBD-based cosmetic products and food. Corix Bioscience is headquartered in Fresno, California, and is now internationally active. The company places special emphasis on the quality of its products and uses only natural and certified ingredients. Corix Bioscience advocates for fair and sustainable production and focuses on environmental protection and sustainability. The future prospects for Corix Bioscience are promising. The company operates in a forward-thinking market, focusing on innovation and sustainability. The developments in the market for cannabinoid-based products allow Corix Bioscience to expand its portfolio and offer more patients a natural alternative to conventional medical therapy. Corix Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corix Bioscience stock

Net Profit Margin of Corix Bioscience is -638.63 % in 2026.

Net Profit Margin of Corix Bioscience changed from -573.44 % to -638.63 %, representing a 11.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Corix Bioscience since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Corix Bioscience with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API
Get Free API Key

Margins — Corix Bioscience

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Corix Bioscience